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Introduction: Delivering synchronous assist during non-invasive ventilation (NIV) is challenging with flow- or
pressure-controlled ventilators, especially in patients with chronic obstructive pulmonary disease (COPD). Neurally
adjusted ventilatory assist (NAVA) uses diaphragm electrical activity (EAdi) to control the ventilator. We evaluated
patient-ventilator interaction in patients with COPD during NIV with pressure support ventilation (PSV) and NAVA
using a recently introduced automated analysis.
Methods: Twelve COPD patients underwent three 30-minute trials: 1) PSV with dedicated NIV ventilator (NIV-PSVVision), 2)
PSV with intensive care unit (ICU) ventilator (NIV-PSVServo-I), and 3) with NIV-NAVA. EAdi, flow, and airway pressure were
recorded. Patient-ventilator interaction was evaluated by comparing airway pressure and EAdi waveforms with
automated computer algorithms. The NeuroSync index was calculated as the percentage of timing errors between
airway pressure and EAdi.
Results: The NeuroSync index was higher (larger error) for NIV-PSVVision (24 (IQR 15 to 30) %) and NIV-PSVServo-I (21 (IQR
15 to 26) %) compared to NIV-NAVA (5 (IQR 4 to 7) %; P <0.001). Wasted efforts, trigger delays and cycling-off errors
were less with NAVA (P <0.05 for all). The NeuroSync index and the number of wasted efforts were strongly correlated
(r2 = 0.84), with a drastic increase in wasted efforts after timing errors reach 20%.
Conclusions: In COPD patients, non-invasive NAVA improves patient-ventilator interaction compared to PSV, delivered
either by a dedicated or ICU ventilator. The automated analysis of patient-ventilator interaction allowed for an objective
detection of patient-ventilator interaction during NIV. In addition, we found that progressive mismatch between neural
effort and pneumatic timing is associated with wasted efforts.Introduction
Non-invasive ventilation (NIV) plays an important role in
managing patients with acute respiratory failure, in particu-
lar in patients with chronic obstructive pulmonary disease
(COPD). In patients with acute hypercapnic exacerbation
of COPD, NIV improves outcome [1-3]. Accordingly, NIV
utilization has increased over time among patients hospital-
ized for acute exacerbation of COPD, whereas the need for
intubation has declined [2]. Despite these positive reports,
some patients treated with NIV fail and require invasive* Correspondence: leo.heunks@radboudumc.nl
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unless otherwise stated.mechanical ventilation [3,4]. Poor patient-ventilator inter-
action may contribute to NIV failure [5,6]. Delivering syn-
chronous non-invasive assist is challenging with flow- or
pressure-controlled systems [7], especially when using ex-
cessively leaky or highly compliant interfaces [8]. Using
ventilators not dedicated to NIV, up to 46% of patients ex-
hibit severe asynchrony [9]. The introduction of dedicated
NIV ventilators and NIV algorithms in ICU ventilators im-
proved patient-ventilator interaction, yet their performance
varies and the inherent limitations of using flow or pressure
to control assist remain [10].
As recommended [11,12], patient-ventilator interaction
can be evaluated by using the diaphragm electrical activity
(EAdi) [13]. Besides its monitoring capabilities, EAdi isral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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a controller signal for ventilatory assist [14]. Recent stud-
ies in heterogeneous groups of critically ill patients show
that non-invasive NAVA (NIV-NAVA) improves patient-
ventilator interaction relative to non-invasive pressure
support ventilation (NIV-PSV) [15-18].
To our knowledge, there are no studies of patient-
ventilator interaction strictly in COPD patients receiving
NIV-NAVA, while these patients are more likely to exhibit
severe patient ventilator asynchrony [19]. In addition, no
study has used the EAdi signal to evaluate patient-ventilator
interaction with dedicated NIV ventilators. Moreover, a new
automated analysis method has recently been introduced in
this journal for quantifying patient-ventilator interaction in a
standardized fashion [20]. This automated analysis allows
detection of asynchronies, such as wasted efforts, but also
makes it easy to detect the more subtle dyssynchronies, such
as trigger delays and cycling-off errors. The present study is
the first to use this analysis method to quantify patient-
ventilator interaction during non-invasive ventilation.
For the above-stated reasons, the aim of the present
study was to evaluate patient-ventilator interaction, using
an automated analysis, in COPD patients with NIV-PSV
delivered by a dedicated NIV ventilator, and NIV-PSV and
NIV-NAVA delivered by an ICU ventilator.
Materials and methods
Study subjects
Adult patients with acute respiratory failure and a medical
history of COPD, admitted to the ICU for non-invasive
ventilation were eligible for inclusion in the study. Patients
with a known neuromuscular disorder, severe hypoxemic
failure (PaO2/FiO2 < 100 mmHg), or hemodynamic instabil-
ity requiring high-dose norepinephrine (>0.5 μg/kg/min)
were excluded. The study was approved by the ethics
committee of the Radboud University Medical Center
(NL33351.091.11) and is in accordance with the ethical
standards laid down in the 1964 Declaration of Helsinki
and its later amendments. All patients gave their informed
consent prior to the study.
Study design
All patients undergoing NIV in our hospital receive a
nasogastric tube to allow adequate feeding and prevent
gastric hyperinflation. COPD patients undergoing NIV re-
ceive a nasogastric tube with a multiple array of electrodes
placed at the distal end (NAVA catheter, 12 French;
Maquet Critical Care, Solna, Sweden). Correct positioning
was established by use of dedicated software. After enroll-
ment and clinical stabilization, each patient received three
30-minute ventilation protocols in the following order:
1. PSV with the BiPAP Vision (Philips Respironics,
Best, The Netherlands), a dedicated NIV ventilator,with pressure support and positive-end expiratory
pressure (PEEP) levels set by the treating physician
(NIV-PSVVision).
2. PSV with the Servo-I (Maquet Critical Care, Solna,
Sweden, NIV software v3.0), an ICU ventilator with
NIV algorithm, with similar PEEP and pressure sup-
port levels (NIV-PSVServo-I).
3. NAVA with the Servo-I (Maquet Critical Care, Solna,
Sweden, NIV software v3.0), where NAVA level was
adjusted to match peak pressure of NIV-PSV, using
manufacturer-supplied software (NIV-NAVA).
BiPAP Vision uses the Auto-Trak Sensitivity algorithm
to trigger and cycle off the ventilator and cannot be set in-
dividually. With NAVA, the back-up mode for triggering
was set at flow triggering. In order to reduce the amount
of leakage on ventilator performance, we chose to use
a tightly fitted oronasal mask (Respironics PerforMax,
Philips, Best, The Netherlands), a frequently used interface
[21]. Switching between ventilators required modifications
in measurement setup and short disconnection of the
patient from the ventilatory circuit. In order to minimize
discontinuation of assist, the order of interventions were
not randomized.
At the end of each ventilator mode, respiratory dis-
comfort was scored by use of a Visual Analog Scale
(from 0 mm (no discomfort) to 100 mm (maximal im-
aginable discomfort)) and arterial blood gas analysis was
performed from an indwelling arterial line.
Data acquisition
Flow, airway pressure (Paw) and EAdi were acquired
from the serial port of the Servo-I at a sampling rate of
62.5 Hz and recorded using dedicated acquisition soft-
ware (Neurovent Research Inc., Toronto, ON, Canada).
The BiPAP Vision does not have a data output port.
Therefore, flow was acquired by placing a pneumotacho-
graph (Fleisch no. 3, Phipps & Bird, Richmond, VA,
USA) between the airflow port of the ventilator and its
tubing, and Paw was acquired by placing a connection
piece between the end of the tubing (after the leakage
port) and the face mask, connected to a pressure trans-
ducer (range ±50 kPa, Freescale Semiconductor, Tempe,
AZ, USA). Both Paw and flow were recorded at a sam-
pling rate of 62.5 Hz and synchronized with the EAdi
using dedicated acquisition software (Neurovent Research
Inc., Toronto, ON, Canada).
Data analysis
Study parameters were calculated from a stable 5-minute
period at the end of each mode on a breath-by-breath
basis using a software routine developed for Matlab
(Mathworks, Natick, MA, USA). Measuring tidal volume
by expiratory flow integration is not precise in the presence
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manuscript. Neural respiratory rate was calculated as the
number of EAdi peaks/min.
Patient-ventilator interaction was evaluated by compar-
ing Paw and EAdi waveforms with automated computer
algorithms [20]. Trigger and cycle-off error (that is dyssyn-
chrony) were calculated as percentages of neural inspira-
tory and expiratory time periods, respectively. Events
where EAdi and Paw were completely dissociated (that is
asynchrony), such as wasted efforts, auto-triggering, mul-
tiple assist during EAdi peak (double triggering) and mul-
tiple EAdi peaks during assist, were assigned 100% error.
To estimate the overall extent of asynchrony and dyssyn-
chrony, we calculated the NeuroSync index by averaging
the percentage errors for all breaths.
Statistical analysis
The D’Agostino and Pearson test was used to test the
normality of distribution. NIV-PSVVision, NIV-PSVServo-I
and NIV-NAVA were compared using the Friedman test
with Dunn’s post hoc testing. Exponential regression ana-
lysis using a least squares fit was performed to test the
relationship between the NeuroSync index and wasted
efforts. A P value <0.05 was considered significant. Stat-
istical analyses were performed with Graphpad Prism 5
(Graphpad Software, San Diego, CA, USA). Results are
reported as median with interquartile ranges.
Results
Twelve patients (one female/eleven male) were enrolled.
One patient was excluded from the offline analysis due
to an EAdi signal with too low an amplitude for auto-
mated patient-ventilator interaction analysis [20]. Patient
characteristics and ventilator settings are shown in
Tables 1 and 2, respectively. After study completion,Table 1 Patient characteristics at study inclusion
Number Age (y) BMI (kg/m2) FEV1 (% pred.) FVC (% pred.) FEV
1 37 25
2 74 23
3 68 38 45 79 42
4 67 34 69 98 70
5 67 27 72 100 53
6 64 26 31 52 43
7 58 26
8 70 28 67 90 55
9 78 22 77 88 64
10 75 17 23 61 28
11 76 25 62 101 45
Recent lung function tests for patient 1, 2 and 7 were unavailable in our hospital, b
correspondence stated a history of COPD. BMI: body mass index; FVC: forced vital c
for Chronic Obstructive Lung Disease classification; PF ratio: PaO2/FiO2.NIV failed in two patients and invasive ventilation was
required. From these two patients, one deceased.
Breathing pattern and respiratory drive
Results for breathing pattern and respiratory drive are
presented in Table 3. EAdi amplitude was higher with
NIV-PSVServo-I compared to NIV-PSVVision (P <0.05).
Peak airway pressure and peak flow were higher with
NIV-PSVVision (P <0.05) compared to NIV-NAVA and
NIV-PSVServo-I.
Patient-ventilator interaction
Figure 1 depicts median values for trigger delays and
cycling-off error during each mode for all individual pa-
tients. NIV-NAVA showed lowest trigger delay com-
pared to NIV-PSVVision and NIV-PSVServo-I (P <0.0001).
NIV-PSVVision and NIV-PSVServo-I had comparable trig-
ger delays, but NIV-PSVServo-I showed more early cycling
off (P <0.05). In absolute values, NIV-PSVVision (95 ±
22 ms) and NIV-PSVServo-I (91 ± 19 ms) showed more
cycling-off error compared to NIV-NAVA (12 ± 6 ms);
P <0.05.
Patient-ventilator interaction, calculated with the Neu-
roSync index, was significantly higher (larger error) with
NIV-PSVVision (24 (interquartile range (IQR) 15 to 30) %)
and NIV-PSVServo-I (21 (IQR 15 to 26) %) compared to
NIV-NAVA (5 (IQR 4 to 7) %; P <0.001).
Figure 2 depicts the correlation between the number
of wasted efforts and the NeuroSync index. The relation-
ship shows as timing errors progressively increased with
NIV-PSVServo-I and NIV-PSVVision a positive association
with the number of wasted efforts, which was certainly
more pronounced above 20% error.
For all three modes of NIV studied, Figure 3 shows a




I 316 Haemoptysis 5
I 308 Exacerbation COPD 3
III 185 Exacerbation COPD 3
II 176 Pneumonia 4
II 180 Exacerbation COPD 5
III 220 Trauma 3
II 143 Exacerbation COPD 6
II 215 Post-op lobectomy 2
II 110 Exacerbation COPD 3
IV 219 Exacerbation COPD 1
II 246 Exacerbation COPD 5
ut clinical pictures of these patients were consistent with COPD and patient
apacity; FEV1: forced expired volume in 1 second; GOLD class: Global Initiative
Table 2 Ventilator settings
Patient PS level PS rise time (s) PS cycle off NAVA level NAVA PEEP FiO2
(cmH2O) (% peak flow) (cmH2O/μV) trigger (μV) (cmH2O) (%)
1 6 0.20 30 0.1 0.5 6 70
2 10 0.20 50 0.8 0.5 8 50
3 8 0.20 70 0.4 0.5 8 50
4 5 0.20 50 0.1 1.0 7 60
5 6 0.20 50 0.1 0.5 4 40
6 5 0.05 50 5.0 0.5 5 30
7 10 0.00 50 0.2 0.5 6 55
8 6 0.20 50 0.2 0.5 6 45
9 6 0.20 50 0.2 0.5 6 70
10 8 0.00 60 0.1 0.5 5 35
11 6 0.20 50 0.2 0.5 6 40
Pressure support (PS) levels and rise time hold for both ventilators, whereas cycle-off criteria is only set for NIV-PSVServo-I. The BiPAP Vision uses the Auto-Trak
Sensitivity algorithm to trigger and cycle off the ventilator and cannot be set individually. PEEP and FiO2 were similar for all three ventilatory modes. FiO2: inspired
oxygen fraction; NAVA: neurally adjusted ventilatory assist; PEEP: positive end-expiratory pressure.
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for every breath, in all patients. Based on the data from
Figure 2, we have inserted a box suggesting ‘acceptable’
synchrony to be ≤20% of neural timings, whereas larger
errors (>20%) represent dyssynchrony.
In the form of a pie chart, Figure 4 plots the distribution
of synchrony (≤20% error, that is inside the box in Figure 3),
dyssynchrony (>20% error, that is outside the box in
Figure 3), and asynchronies for each mode. Wasted efforts
were the most prevalent type of asynchrony and differed
between ventilator modes (P <0.001). Post hoc analysis in-
dicated significantly more wasted efforts with NIV-
PSVVision compared to NIV-NAVA. Other asynchronies,
such as multiple EAdi during assist, double triggering and
auto-triggering were uncommon.
Blood gas values and respiratory discomfort
There were no differences in blood gas values (Table 4)
and respiratory discomfort with NIV-PSVVision (45 (IQR
31 to 69) mm), NIV-PSVServo-I (60 (IQR 41 to 65) mm),
and NIV-NAVA (45 (IQR 33 to 75) mm).Table 3 Breathing pattern and respiratory drive
NIV-PSVVision NIV-PSVServo-I NIV-NAVA
Peak EAdi (μV) 25.6 (18.6 - 43.5)* 34.7 (18.8 - 49.0) 23.8 (17.1 - 48.0)
Peak airway
pressure (cmH2O)
15.3 (13.0 - 18.5)*# 12.5 (10.4 - 15.2) 12.9 (11.7 - 16.0)
Inspiratory peak
flow (L/min)
92.5 (72.1 - 110.0)*# 54.1 (46.8 - 63.2) 45.6 (38.7 - 61.1)
Neural resp. rate
(breaths/min)
22.7 (17.6 - 27.0) 25.2 (18.5 - 28.2) 25.1 (18.3 - 31.7)
*NIV-PSVVision vs. NIV-PSVServo-I (P <0.05),
#NIV-PSVVision vs. NIV-NAVA (P <0.05).
EAdi, electrical activity of the diaphragm; NAVA: neurally adjusted ventilatory
assist; NIV: non-invasive ventilation; PSV: pressure support ventilation.Discussion
This study provides insight into the interaction between
patient and ventilator during non-invasive ventilation
with different types of ventilators and modes in patients
with COPD. First, we show that neurally adjusted non-
invasive ventilation synchronizes assist to inspiratory
effort in patients with COPD, whereas dedicated NIV
ventilator or ICU ventilator pressure support modes do
not ensure acceptable patient-ventilator interaction in in-
dividual patients. Second, wasted efforts increase drastic-
ally after timing errors between EAdi and airway pressure
reach 20%. Third, automated analysis of patient-ventilator
interaction using computer algorithms allows objective de-
tection of patient-ventilator interaction during NIV.Patient-ventilator interaction
For effective unloading of the respiratory muscles with
NIV, the ventilator should cycle in synchrony with the
patient’s neural respiratory drive [5]. Our results are con-
sistent with previous studies that showed improved
patient-ventilator interaction with neurally compared to
pneumatically controlled mechanical ventilation [15-18],
however, several differences between these and the current
study should be noted. First, we included only patients
with COPD, which are more likely to exhibit poor patient-
ventilator interaction [19]. Second, dedicated NIV-NAVA
and NIV-PSV software was used instead of software for in-
vasive ventilation in the previous studies [16,17]. This is
important as the software for invasive ventilation lacks
leakage compensation thereby allowing auto-triggering at
high leakage. Indeed, auto-triggering up to 6 breaths/min
was found with NIV-NAVA using the invasive software
[16], whereas we found only up to 1 breath/min. Third, a
Figure 1 Trigger delay (left) and cycling-off error (right) for the different ventilator modes. Y-axis for cycle-off error: positive values indicate
late cycling off, and negative values indicate early cycling off. *P <0.05. NAVA: neurally adjusted ventilatory assist; NIV: non-invasive ventilation;
PSV: pressure support ventilation.
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study. In bench-test comparisons, including the ventila-
tor used in our study, PSV delivered by dedicated
NIV ventilators allowed better patient-ventilator inter-
action than ICU ventilators with NIV algorithms [10,22].Figure 2 Correlation between the number of wasted efforts
and the NeuroSync index. Note that for this regression analysis,
the NeuroSync index was recalculated without wasted efforts to
avoid mathematically coupled variables, and is thus consequently
primarily a measure of dyssynchrony (trigger and cycle-off errors).
Accordingly this correlation shows that progressive dyssynchrony,
increases the number of wasted efforts. NAVA: neurally adjusted
ventilatory assist; NIV: non-invasive ventilation; PSV: pressure
support ventilation.Lastly, an automated analysis method for quantifying
patient-ventilator asynchronies and the more subtle dys-
synchronies was used [20], allowing a more objective de-
tection of patient-ventilator interaction.
The present study showed a small trigger delay with
NIV-NAVA, which substantially increased with NIV-
PSVServo-I and NIV-PSVVision. These findings agree with
previous work comparing NIV-PSVServo-I and NIV-NAVA
[15], but oppose a previous bench test showing longer
trigger delay for NIV-PSVServo-I compared to NIV-
PSVVision [22]. NAVA triggers on the increase in EAdi and
thus represents the duration to increase EAdi, to process
the signal and to open the inspiratory valve. Our average
trigger delay of about 50 ms with NIV-NAVA is in the
range previously reported for NIV-NAVA [15,16,18]. In
contrast, pneumatic triggering is more complex and con-
siderably affected by leakage, which can only be partly
compensated for by dedicated NIV algorithms [7].
Synchronized termination of assist is another key com-
ponent to maintain good patient-ventilator interaction. As
depicted in Figure 1, NIV-PSVVision showed large inter-
subject variability in early and late cycling off, whereas
NIV-PSVServo-I showed primarily early cycling off.
Cycling-off error in NIV-NAVA was negligible, which
could be anticipated since its definition for cycling off is
similar to the algorithm used to quantify cycling-off error
(70% of peak EAdi). These findings agree with previous
suggestions that NIV algorithms for ICU ventilators tend
to increase the incidence of premature cycling off [7].
Wasted efforts are inspiratory efforts not rewarded by
ventilatory assist, which can increase the work of breathing
[5,6]. In the present study, 4.3% and 2.5% of inspiratory ef-
forts were unnoticed by the ventilator for NIV-PSVVision
and NIV-PSVServo-I, respectively. In contrast, NIV-NAVA
Figure 3 Breath density graph for relative trigger (Y-axis) and cycling-off (X-axis) errors, for all breaths in all patients, during each
ventilator mode. The small white ‘box’ in the center of each graph indicates the limit between synchrony (neural efforts matched to assist
delivery with less than 20% error - inside the box) and dyssynchrony (neural efforts poorly related to assist delivery, >20% error - outside the box).
These breath-density graphs show for NIV-NAVA a concentrated breath density in the center, which should be anticipated since it is driven by
EAdi. With NIV-PSVVision and NIV-PSVServo-I breaths are more spread out and have considerable proportions of dyssynchronous breaths compared
to NIV-NAVA. NAVA: neurally adjusted ventilatory assist; NIV: non-invasive ventilation; PSV: pressure support ventilation.
Doorduin et al. Critical Care 2014, 18:550 Page 6 of 8
http://ccforum.com/content/18/5/550effectively prevented wasted efforts, confirming previous
studies [15,16,18]. Furthermore, as depicted in Figure 2, we
found that wasted efforts increase drastically after timing
errors reach 20%. This suggests that the limits of the Neu-
roSync index and the definition of ‘acceptable’ synchrony
should be kept below 20%, as indicated by the centered
boxes in Figure 3.
Breathing pattern and respiratory drive
EAdi in the present study was higher with NIV-
PSVServo-I compared to NIV-PSVVision, which is difficult
to explain. Lack of difference in blood gases or respira-
tory rates contradict that increased EAdi with NIV-PSV
was ventilation related. Premature cycling off with NIV-
PSVServo-I could be a probable cause for increased EAdi,Figure 4 Percentage of synchronous, dyssynchronous and asynchron
and multiple assist during EAdi) breaths for the different ventilator m
ventilation; PSV: pressure support ventilation.since this results in unassisted inspiration in the last part
of inspiration. It should also be noted that the design of
the respiratory circuit and assist delivery of the BiPAP
Vision is fundamentally different from the Servo-I. For
example, the BiPAP Vision system has a large intentional
leakage. Consequently, from Ohm’s law it follows that
higher flow is required to maintain the preset pressure
level (Table 3). Higher flow might have resulted in
higher CO2 clearance in the interface and upper airways
and a consequent reduction in dead space leading to re-
duced respiratory drive.
Clinical implications
Good patient-ventilator interaction is one of the key fac-
tors for clinical success of NIV, thus solving poorous (wasted efforts, auto-triggering, multiple EAdi during assist,
odes. NAVA: neurally adjusted ventilatory assist; NIV: non-invasive
Table 4 Blood gas values
NIV-PSVVision NIV-PSVServo-I NIV-NAVA
pH 7.38 (7.36 - 7.46) 7.38 (7.36 - 7.45) 7.38 (7.36 - 7.45)
PaO2 (mmHg) 92 (77 - 106) 105 (84 - 113) 95 (77 - 98)
PaCO2 (mmHg) 44 (39 - 64) 44 (33 - 59) 41 (32 - 60)
HCO3− (mmol/L) 27 (23 - 32) 26 (21 - 31) 27 (22 - 30)
NAVA: neurally adjusted ventilatory assist; NIV: non-invasive ventilation; PSV:
pressure support ventilation.
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tential clinical value. In our study, we demonstrate that
progressive mismatch between timing of the patient’s
neural drive and the response of the ventilator is associ-
ated with increased number of wasted efforts. It is
tempting to speculate that improving synchrony between
patient neural effort and ventilator assist improves out-
come in COPD patients, but it should be noted that our
study is a short-term physiological study performed in a
center with extensive experience in NIV, both with PSV
and NAVA. In addition, a limitation of the present study
is the limited number of patients, which hamper drawing
generalized conclusions.
Differences in patient-ventilator interaction between
ventilator modes did not affect blood gas values, in par-
ticular pH, and respiratory discomfort. In part, this re-
sults from the timing of study inclusion, after initial
stabilization on NIV. At inclusion in the study, blood pH
(around 7.38) was already increased, making it more dif-
ficult to detect changes in pH and respiratory discomfort
caused by different ventilator modes. In this context it
should also be mentioned that NIV modes were not per-
formed in a random order. Nevertheless, we performed
our measurement after initial stabilization on NIV mak-
ing it unlikely that the patients’ respiratory status was
worse at the beginning of the study than at the end. Fu-
ture studies, which randomize between NAVA and PSV
at admission, are necessary to ascertain whether or not
improved patient-ventilator interaction in the acute
phase of NIV translates to better NIV outcomes.Conclusions
Automated analysis of patient-ventilator interaction showed
that non-invasive NAVA improves patient-ventilator inter-
action compared to PSV in COPD patients. Moreover,
this is not different when PSV is delivered by a dedi-
cated NIV ventilator. In addition, progressive mismatch
between neural effort and pneumatic timing is strongly
associated with the number of wasted efforts. Whether
NAVA is more successful in correcting pH in patients
with acute hypercapnic exacerbation of COPD should
be addressed in future studies that randomize between
NAVA and PSV at admission.Key messages
 Non-invasive NAVA improves patient-ventilator
interaction compared to PSV in COPD patients.
 Progressive mismatch between neural effort and
pneumatic timing is strongly associated with the
number of wasted efforts.
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